Australia's largest stock trading and investment forum Australia's #1 stock forum

BLT benitec biopharma limited

5.00%

21.0¢

Dicerna & Benitec, page-4

First 4 Last

Share
Profile

Follow
Blane66

1,853 Posts.

9

07/04/18

14:24

Post #: 32291170
Share

Originally posted by lawrence1967 ↑

You're right. I unknowingly conflated 401 and 501.

From our website -

"

We are also developing a follow-on compound utilizing our proprietary ddRNAi proprietary technology to silence EGFR. Named, BB-501, early stage iterations of this candidate are currently being tested in preclinical animal testing using xenograft tumour models."

Expand

So again, that doesn’t leave us with much confidence of any great re-rate in the near future regarding ddrnai.

BLT Price at posting: 21.0¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

HotCopper Highlights Week 35: X2M, AnteoTech and Brighstar dominate forum chatter

MEM

Memphasys receives early Thai FDA Felix approval

NVA

Nova Minerals achieves key milestone on path to Alaskan antimony production

4DX

4DMedical posts FY26 revenue growth as commercial deployment ramps up

TGN

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

D3E

D3 Energy detects gas in South African helium hunt well

CVL

Civmec earnings: Profit climbs as $1.4b order book backs FY27 growth

SEN

Senetas experiences stronger cash flow as revenue rises, flags FY27 sales pipeline

AS2

Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus

IMR

Imricor Med and Philips launch commercial iMR lab solution

First 4 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Dicerna & Benitec, page-4

Top Stories

HotCopper Highlights Week 35: X2M, AnteoTech and Brighstar dominate forum chatter

Memphasys receives early Thai FDA Felix approval

Nova Minerals achieves key milestone on path to Alaskan antimony production

4DMedical posts FY26 revenue growth as commercial deployment ramps up

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

D3 Energy detects gas in South African helium hunt well

Civmec earnings: Profit climbs as $1.4b order book backs FY27 growth

Senetas experiences stronger cash flow as revenue rises, flags FY27 sales pipeline

Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus

Imricor Med and Philips launch commercial iMR lab solution

Featured News